These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7660832

  • 21. [Electrophysiological experimental study of a novel class III antiarrhythmic drug RG-2].
    Rozenshtraukh LV, Fedorov VV, Reznik AV, Sharifov OF, Beloshapko GG, Iushmanova AV, Golitsyn SP, Ruda MIa, Chazov EI.
    Kardiologiia; 2003; 43(9):56-63. PubMed ID: 14593371
    [Abstract] [Full Text] [Related]

  • 22. Cardiohemodynamic and electrophysiological effects of anti-influenza drug oseltamivir in vivo and in vitro.
    Kitahara K, Nakamura Y, Tsuneoka Y, Adachi-Akahane S, Tanaka H, Yamazaki H, Takahara A, Yamazaki J, Ikeda T, Sugiyama A.
    Cardiovasc Toxicol; 2013 Sep; 13(3):234-43. PubMed ID: 23420508
    [Abstract] [Full Text] [Related]

  • 23. Effects of HNS-32, a novel antiarrhythmic agent, on guinea-pig myocardium.
    Noguchi K, Kase J, Saitoh M, Masumiya H, Saitoh M, Nakazawa T, Tanaka Y, Tanaka H, Hashimoto K, Shigenobu K.
    Pharmacology; 2002 Jan; 64(1):36-42. PubMed ID: 11731720
    [Abstract] [Full Text] [Related]

  • 24. Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugs.
    Millar JS, Vaughan Williams EM.
    Br J Pharmacol; 1983 Jul; 79(3):701-9. PubMed ID: 6652350
    [Abstract] [Full Text] [Related]

  • 25. Calcium channel antagonistic effects of AH-1058, a novel antiarrhythmic drug, on guinea-pig myocardium.
    Tanaka H, Ichikawa T, Matsui S, Okazaki K, Masumiya H, Kawanishi T, Shigenobu K.
    Res Commun Mol Pathol Pharmacol; 1999 Jul; 104(1):13-21. PubMed ID: 10604274
    [Abstract] [Full Text] [Related]

  • 26. The in vivo electrophysiological actions of the new potassium channel blockers, tedisamil and UK 68,798.
    Beatch GN, MacLeod BA, Abraham S, Walker MJ.
    Proc West Pharmacol Soc; 1990 Jul; 33():5-8. PubMed ID: 2274546
    [No Abstract] [Full Text] [Related]

  • 27. The comparative antiarrhythmic and proarrhythmic activity of a 3,7-diheterobicyclo[3.3.1]nonane, BRB-I-28, and lidocaine in the 1-4-day-old infarcted dog heart.
    Fazekas T, Scherlag BJ, Mabo P, Berlin KD, Garrison GL, Chen CL, Sangiah S, Patterson E, Lazzara R.
    Acta Physiol Hung; 1993 Jul; 81(3):289-99. PubMed ID: 8197884
    [Abstract] [Full Text] [Related]

  • 28. Haemodynamic, electrocardiographic, electrophysiologic and pharmacokinetic activity of 4'-hydroxypropranolol in dogs.
    Muir WW, Sams RA, Schall SF.
    J Vet Pharmacol Ther; 1996 Aug; 19(4):259-67. PubMed ID: 8866453
    [Abstract] [Full Text] [Related]

  • 29. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
    Dukes ID, Cleemann L, Morad M.
    J Pharmacol Exp Ther; 1990 Aug; 254(2):560-9. PubMed ID: 2384886
    [Abstract] [Full Text] [Related]

  • 30. Selective Ik blocker almokalant exhibits class III--specific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordings.
    Darpö B, Vallin H, Almgren O, Bergstrand R, Insulander P, Edvardsson N.
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):530-40. PubMed ID: 8569212
    [Abstract] [Full Text] [Related]

  • 31. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    Pugsley MK, Saint DA, Hayes ES, Abraham S, Walker MJ.
    Eur J Pharmacol; 2015 Aug 15; 761():330-40. PubMed ID: 26086860
    [Abstract] [Full Text] [Related]

  • 32. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL, Sulkowski T, Much DR, Wendt RL.
    Arzneimittelforschung; 1983 Aug 15; 33(9):1258-68. PubMed ID: 6685506
    [Abstract] [Full Text] [Related]

  • 33. Antiarrhythmic properties of tetrodotoxin against occlusion-induced arrhythmias in the rat: a novel approach to the study of the antiarrhythmic effects of ventricular sodium channel blockade.
    Abraham S, Beatch GN, MacLeod BA, Walker MJ.
    J Pharmacol Exp Ther; 1989 Dec 15; 251(3):1166-73. PubMed ID: 2557414
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Electrophysiological actions of a new antiarrhythmic drug, bisaramil, on isolated heart preparations.
    Paroczai M, Karpati E, Marko R, Kecskemeti V.
    Pharmacol Res; 1992 Jan 15; 25(1):75-85. PubMed ID: 1738760
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo.
    Eglen RM, Lee CH, Smith WL, Johnson LG, Whiting RL, Hegde SS.
    J Pharmacol Exp Ther; 1993 Aug 15; 266(2):535-43. PubMed ID: 8355189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.